Company intelligence / Profile preview

JenaSurgical

Jena, Thuringia, Germanyjenasurgical.com ↗

Ownership: Private
Development stage: Commercial

Overview

JenaSurgical’s portfolio of advanced surgical lasers—including holmium and CO₂ systems—are commercially available worldwide. Their devices are used in minimally invasive surgeries across urology, gynecology, ENT/otorhinolaryngology, oncology and general/microsurgery. The technology emphasizes safety, precision and speed with proven clinical adoption in over seventy countries. No clinical trial results are reported as the products are medical devices rather than therapeutics.

Therapeutic areas: Men's HealthOtherDermatologyNephrologyWomen's Health
Modalities: Device (Laser device)Medical device (Morcellator)CO₂ laser systemHolmium laser system (Ho:YAG)Thulium laser system (Tm:YAG + Raman module)Morcellation system for tissue extraction
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on JenaSurgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JenaSurgical.

Explore the full profile